Bionomics(NASDAQ:BNOX) 
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the ...
Website: https://www.bionomics.com.au
Founded: 1996
IPO Price: $12.35 (Dec 16, 2021)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-06-27
P
O 0.75
H 0.78
L 0.74
C 0.74
V 33,230
10EMA 0.74
20EMA 0.74
60EMA 0.74
120EMA 0.74
250EMA 0.74